Alzamend Neuro Inc Stock price
Is Alzamend Neuro Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,120 stocks worldwide.
Key metrics
Alzamend Neuro Inc Stock Analysis
Analyst Opinions
7 Analysts have issued a Alzamend Neuro Inc forecast:
Analyst Opinions
7 Analysts have issued a Alzamend Neuro Inc forecast:
Don't miss a Thing! We will send you all news about Alzamend Neuro Inc directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Alzamend Neuro Inc Stock News
Company Profile
Alzamend Neuro, Inc. is a preclinical stage biopharmaceutical company, which engages in the manufacture of pharmaceutical products. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders. The company was founded on February 26, 2016 by Milton C. Ault, III and is headquartered in Tampa, FL.
| Head office | United States |
| CEO | Mr. Jackman |
| Employees | 5 |
| Founded | 2016 |
| Website | alzamend.com |


